University of Connecticut
Storrs, Connecticut, 06269, United States
NCT Number: NCT06170866
The goal of this interventional study is to culturally adapt and determine feasibility of the peer partner training program and the peer-supported mobile health physical activity intervention in older Latin/Hispanic people with Parkinson's disease.
The main question[s] it aims to answer are:
* What is the feasibility of the peer partner training program? * What is the feasibility of the peer-supported mobile health physical activity intervention? * What are the effects of the peer-supported mobile health physical activity intervention on physical activity, motivation, depression, apathy and self-efficacy?
Participants will be asked to:
* Wear a research-grade activity monitor, Actigraph GT9X device for 10 days at the beginning and end of the study. * Watch 11 educational videos about Parkinson´s disease and exercise and attend two virtual educational sessions. * Connect with another person with Parkinson´s disease one time a week on a virtual meeting platform for 8 weeks. * Use Fitbit activity monitors and connect with other participants through the Fitbit application for 8 weeks. * Attend a weekly online exercise class for 8 weeks with other people with Parkinon´s disease.
Looking for future studies?
Notify Me50 year and older
All sexes
Interventional
Not applicable
Storrs, Connecticut, 06269, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
-≥ 29 on Telephone Interview for Cognitive Status (TICS)
-≥ 50 years of age
Exclusion criteria
Use of a culturally and linguistically tailored intervention that uses mobile health technology plus social support to increase engagement in physical activity in the management of Parkinson´s disease.
Time frame: After completion of the entire intervention (11 weeks)
A standardized measure of acceptability that indicates percent agreement with acceptability of the intervention ranging from 20-100%. Higher scores indicate agreement (better outcome) with the acceptability of the intervention.
Time frame: After completion of the entire intervention (11 weeks)
A standardized measure of appropriateness that indicates percent agreement with appropriateness of the intervention ranging from 20-100%. Higher scores indicate more agreement (better outcome) with the appropriateness of the intervention.
Time frame: After completion of the entire intervention (11 weeks)
A standardized measure of feasibility that indicates percent agreement with feasibility of the intervention ranging from 20-100%. Higher scores indicate more agreement (better outcome) with the feasibility of the intervention.
Time frame: 10 days at baseline and post-intervention (approximately 12 to 14 weeks)
Steps per day measured using a research-grade activity monitor will provide group mean change in physical activity from baseline to post-intervention.
Time frame: Baseline and post Intervention (approximately 12 to 14 weeks)
The Behavioral Regulation in Exercise Questionnaire-2, Relative Autonomy Index, is a standardized, 19-item survey that evaluates motivation for exercise. The scores range from -24 to +20 with higher scores indicating increased motivation or better outcomes. The group mean change score is presented.
Time frame: Pre and post intervention (approximately 12 to 14 weeks)
The Parkinson's Disease Questionnaire-39 (PDQ-39) is a 39-item, self-report survey that assess quality of life. The scores range from 0-100 and a decrease indicates an improvement in quality of life. The group mean change total scores will be evaluated.
Time frame: Pre and post intervention (approximately 12 to 14 weeks)
The Geriatric Depression Scale (GDS) -15, is a 15-item self-report measure of depression in older adults. The score ranges from 0-15 with higher scores indicating higher levels of depression (worse outcome). Group mean change scores related to depression are reported.
UConn Health
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05510739
Basal Ganglia Diseases, Behavior
Stockholm, Sweden
View Trial DetailsNCT06646523
Basal Ganglia Diseases, Behavior
Belo Horizonte, Minas Gerais, Brazil
View Trial DetailsNCT05948956
Basal Ganglia Diseases, Behavior
Ann Arbor, Michigan, United States
View Trial DetailsNCT06576817
Basal Ganglia Diseases, Behavior
Yakima, Washington, United States
View Trial Details